| 10B7 | 1F7 | 26A1 | 8C10 |
---|
Donor
| CMV5 | CMV5 | CMV7 | CMV7 |
Doubling Time (days)
| 4 | 4 | 4 | 4 |
IgG Subclass
| IgG1 | IgG1 | IgG1 | IgG2 |
BEIA-CMV
a
| - | - | + | + |
gB ELISA
| + | - | - | + |
gH ELISA
| - | + | - | - |
HELF binding
b
| - | - | - | - |
HUVEC binding
b
| - | - | - | - |
HCMV neutralization
c
| 64.72 ± 11.34 | 47.23 ± 2.98 | 86.34 ± 8.15 | 52.3 ± 13.34 |
- a. Antibodies were tested using the BEIA CMV ELISA assay
- b. Antibodies were tested for binding to uninfected HELF and HUVEC by immunohistochemistry.
- c. Antibodies were tested using the HCMV microneutralization assay, with the HCMV AD169 strain and HELF. Results are expressed as % of inhibition of virus infectivity. Data represent the mean ± s.d. of 3–4 experiments.